Using genetic testing to personalize treatment for PTSD in veterans
Official title: Personalized Pharmacotherapy Using Pharmacogenetics in Veterans Seeking Treatment for Mental Health
Run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · NCT06335043 · Data updated 2026-11-12
This study is testing if using genetic testing can help personalize mental health treatments for veterans and members of the Canadian Armed Forces and Royal Canadian Mounted Police with PTSD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 155 (estimated) |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Academic / other |
| Locations | 1 site (London, Ontario) |
| Status | Recruiting |
| Started | April 25, 2024 |
| Main results expected | April 25, 2027 |
| Study ends | April 25, 2027 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT06335043 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include veterans or current members of the CAF or RCMP who are patients at the London St. Joseph's OSI Clinic and have a current diagnosis of an operational stress injury.
✕Probably not a fit
Patients who are unable to provide informed consent or do not meet the eligibility criteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational clinical trial evaluates the effectiveness of pharmacogenetic testing (PGx) to tailor mental health treatments for veterans and members of the Canadian Armed Forces and Royal Canadian Mounted Police. Participants, including both psychiatrists and patients, will complete surveys to assess their knowledge and attitudes towards PGx. Patients can choose to opt-in for PGx-guided treatment, which involves sharing genetic test results with their psychiatrists to inform treatment planning. The study aims to gather insights on the integration of PGx in clinical practice and its impact on treatment outcomes.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and personalized treatment options for veterans suffering from PTSD.
How similar studies have gone: While pharmacogenetic testing is a growing field, this specific application in PTSD treatment for veterans is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Provider participant:
* Are at least 18 years of age;
* Speak and write English;
* Currently working as an OSI Clinic Psychiatrist at the London St. Joseph's OSI Clinic.
* Psychiatrist with an active caseload of patients being treated for OSIs.
* Patient participant:
* Veteran (patient) CAF or RCMP member;
* Are at least 18 years of age;
* Are a current patient at the London St. Joseph's OSI Clinic;
* Current diagnosis of an OSI;
* Speak and write English;
* Consents to the use of CROMIS data for the purpose of this study; and
* Consents to the use of prior OSI Clinic data for research purposes (if you have been a patient at the OSI Clinic prior to this study, the research team will use past OSI Clinic data to observe changes over time).
Exclusion Criteria:
* Participants (provider or patients) who are unable to, or do not, provide informed consent for participation.
Where it's running
-
MacDonald Franklin OSI Research and Innovation Centre
London, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Natalie Ein, PhD
- Email: natalie.ein@sjhc.london.on.ca
- Phone: 416-573-9047
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Intraoperative diuretics during deceased-donor kidney transplants
This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.
-
Faster brain stimulation for PTSD and depression
This pilot study tests a quicker brain stimulation schedule (accelerated iTBS) to see if it’s doable, safe, and tolerable for adults with PTSD and major depression.
-
Bladder Management and Quality of Life in Young Adults with Spina Bifida
This study asks teens and young adults with spina bifida how different bladder care methods affect their daily life and happiness.
-
What factors predict delayed behavior problems in children after procedural sedation
This study will test which factors make children aged 1–17 more likely to have delayed behavior problems (such as sleep trouble, anxiety, or aggression) after procedural sedation in emergency departments and dental clinics.
-
Gentamicin dosing in neonates: checking if extended-interval dosing still works
This study checks whether extended-interval gentamicin dosing in newborns up to 7 days old still achieves safe and effective drug levels.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.